
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 173538
[patent_doc_number] => 07658917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Modulators of amyloid aggregation'
[patent_app_type] => utility
[patent_app_number] => 10/463729
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 37841
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10463729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/463729 | Modulators of amyloid aggregation | Jun 16, 2003 | Issued |
Array
(
[id] => 6925439
[patent_doc_number] => 20050238694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Satiety inducing composition'
[patent_app_type] => utility
[patent_app_number] => 10/519657
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7649
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519657 | Satiety inducing composition | Jun 12, 2003 | Issued |
Array
(
[id] => 7354774
[patent_doc_number] => 20040048783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Acidic insulin preparations having improved stability'
[patent_app_type] => new
[patent_app_number] => 10/461740
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4192
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10461740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/461740 | Acidic insulin preparations having improved stability | Jun 12, 2003 | Abandoned |
Array
(
[id] => 296069
[patent_doc_number] => 07541339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Par-2-activating peptide derivative and pharmaceutical composition using the same'
[patent_app_type] => utility
[patent_app_number] => 10/517803
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4462
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517803 | Par-2-activating peptide derivative and pharmaceutical composition using the same | Jun 9, 2003 | Issued |
Array
(
[id] => 6805366
[patent_doc_number] => 20030232760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Conjugates useful in the treatment of prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/456342
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12466
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456342
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456342 | Conjugates useful in the treatment of prostate cancer | Jun 5, 2003 | Abandoned |
Array
(
[id] => 7270347
[patent_doc_number] => 20040058865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Homing peptide multimers, their preparation and uses'
[patent_app_type] => new
[patent_app_number] => 10/433212
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6606
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433212 | Homing peptide multimers, their preparation and uses | Jun 3, 2003 | Abandoned |
Array
(
[id] => 7270339
[patent_doc_number] => 20040058857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Method of treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/433596
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20340
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433596 | Method of treating cancer | May 28, 2003 | Abandoned |
Array
(
[id] => 5726303
[patent_doc_number] => 20060057063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Medicaments'
[patent_app_type] => utility
[patent_app_number] => 10/515248
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5842
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515248 | Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent | May 20, 2003 | Issued |
Array
(
[id] => 728655
[patent_doc_number] => 07041649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'Method for treating neurological conditions and inducing immunosuppression with cephaibols'
[patent_app_type] => utility
[patent_app_number] => 10/442848
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3383
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10442848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/442848 | Method for treating neurological conditions and inducing immunosuppression with cephaibols | May 20, 2003 | Issued |
Array
(
[id] => 7367166
[patent_doc_number] => 20040006013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Histogranin peptide and their analgesic use'
[patent_app_type] => new
[patent_app_number] => 10/437435
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7724
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437435 | Histogranin peptides and their analgesic use | May 13, 2003 | Issued |
Array
(
[id] => 1037552
[patent_doc_number] => 06872701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Glycopeptide phosphonate derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/436341
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23183
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10436341
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/436341 | Glycopeptide phosphonate derivatives | May 11, 2003 | Issued |
Array
(
[id] => 7367027
[patent_doc_number] => 20040006000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Novel formulations'
[patent_app_type] => new
[patent_app_number] => 10/429508
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6255
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429508 | Novel formulations | May 4, 2003 | Abandoned |
Array
(
[id] => 658286
[patent_doc_number] => 07105482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/429174
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17693
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105482.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429174 | Methionine aminopeptidase-2 inhibitors and methods of use thereof | May 1, 2003 | Issued |
Array
(
[id] => 975599
[patent_doc_number] => 06933275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-23
[patent_title] => 'Protein kinase C peptides for use in withdrawal'
[patent_app_type] => utility
[patent_app_number] => 10/428280
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 51
[patent_no_of_words] => 12928
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933275.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428280 | Protein kinase C peptides for use in withdrawal | Apr 30, 2003 | Issued |
Array
(
[id] => 690804
[patent_doc_number] => 07074765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4'
[patent_app_type] => utility
[patent_app_number] => 10/426968
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12380
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10426968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/426968 | Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 | Apr 30, 2003 | Issued |
Array
(
[id] => 509621
[patent_doc_number] => 07199102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Orally administered peptides synergize statin activity'
[patent_app_type] => utility
[patent_app_number] => 10/423830
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25357
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/199/07199102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423830
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423830 | Orally administered peptides synergize statin activity | Apr 24, 2003 | Issued |
Array
(
[id] => 7291812
[patent_doc_number] => 20040110928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Peptide conjugates for drug delivery'
[patent_app_type] => new
[patent_app_number] => 10/240430
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3766
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240430
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240430 | Peptide conjugates for drug delivery | Apr 14, 2003 | Abandoned |
Array
(
[id] => 6678878
[patent_doc_number] => 20030229019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/413160
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13389
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10413160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/413160 | Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof | Apr 13, 2003 | Abandoned |
Array
(
[id] => 696108
[patent_doc_number] => 07071425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Weighing machine having a central distributor to scales'
[patent_app_type] => utility
[patent_app_number] => 10/509815
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2153
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509815 | Weighing machine having a central distributor to scales | Apr 6, 2003 | Issued |
Array
(
[id] => 6822094
[patent_doc_number] => 20030220255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'GLP-1 agonist and cardiovascular complications'
[patent_app_type] => new
[patent_app_number] => 10/406426
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6079
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406426 | GLP-1 agonist and cardiovascular complications | Apr 2, 2003 | Abandoned |